SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression

Abstract Mantle cell lymphoma (MCL) is highly aggressive and its treatment remains challenging, understanding its pathogenesis is critical for future targeted therapy. SUMO specific proteases 1 (SENP1) is an important protein that regulates the balance between SUMOylation and deSUMOylation. We found...

Full description

Saved in:
Bibliographic Details
Main Authors: Yali Zhang, Yanni Ma, Guixian Wu, Mingling Xie, Chengxin Luo, Xiangtao Huang, Feng Tian, Jieping Chen, Xi Li
Format: Article
Language:English
Published: Nature Publishing Group 2021-07-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-021-00578-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726778941112320
author Yali Zhang
Yanni Ma
Guixian Wu
Mingling Xie
Chengxin Luo
Xiangtao Huang
Feng Tian
Jieping Chen
Xi Li
author_facet Yali Zhang
Yanni Ma
Guixian Wu
Mingling Xie
Chengxin Luo
Xiangtao Huang
Feng Tian
Jieping Chen
Xi Li
author_sort Yali Zhang
collection DOAJ
description Abstract Mantle cell lymphoma (MCL) is highly aggressive and its treatment remains challenging, understanding its pathogenesis is critical for future targeted therapy. SUMO specific proteases 1 (SENP1) is an important protein that regulates the balance between SUMOylation and deSUMOylation. We found that SENP1 was upregulated in MCL patient samples and cell lines. Knockdown of SENP1 could inhibit the proliferation and promote the apoptosis of MCL cells. We also found that SENP1 knockdown caused inhibition of the JAK-STAT5 pathway and upregulation of tumor suppressor cytokine signaling 2 (SOCS2). Moreover, MCL tumor growth in vivo was significantly suppressed after SENP1 knockdown in a xenograft nude mouse model. In summary, our results showed that SENP1 is involved in the pathogenesis of MCL and may be a potential therapeutic target.
format Article
id doaj-art-979a48d7da584b8d910f71830feffd07
institution DOAJ
issn 2058-7716
language English
publishDate 2021-07-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-979a48d7da584b8d910f71830feffd072025-08-20T03:10:05ZengNature Publishing GroupCell Death Discovery2058-77162021-07-017111010.1038/s41420-021-00578-xSENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expressionYali Zhang0Yanni Ma1Guixian Wu2Mingling Xie3Chengxin Luo4Xiangtao Huang5Feng Tian6Jieping Chen7Xi Li8Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hepatobiliary Surgery, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Department of Hematology, Southwest Hospital, Army Medical University (Third Military Medical University)Abstract Mantle cell lymphoma (MCL) is highly aggressive and its treatment remains challenging, understanding its pathogenesis is critical for future targeted therapy. SUMO specific proteases 1 (SENP1) is an important protein that regulates the balance between SUMOylation and deSUMOylation. We found that SENP1 was upregulated in MCL patient samples and cell lines. Knockdown of SENP1 could inhibit the proliferation and promote the apoptosis of MCL cells. We also found that SENP1 knockdown caused inhibition of the JAK-STAT5 pathway and upregulation of tumor suppressor cytokine signaling 2 (SOCS2). Moreover, MCL tumor growth in vivo was significantly suppressed after SENP1 knockdown in a xenograft nude mouse model. In summary, our results showed that SENP1 is involved in the pathogenesis of MCL and may be a potential therapeutic target.https://doi.org/10.1038/s41420-021-00578-x
spellingShingle Yali Zhang
Yanni Ma
Guixian Wu
Mingling Xie
Chengxin Luo
Xiangtao Huang
Feng Tian
Jieping Chen
Xi Li
SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
Cell Death Discovery
title SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
title_full SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
title_fullStr SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
title_full_unstemmed SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
title_short SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
title_sort senp1 promotes mcl pathogenesis through regulating jak stat5 pathway and socs2 expression
url https://doi.org/10.1038/s41420-021-00578-x
work_keys_str_mv AT yalizhang senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT yannima senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT guixianwu senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT minglingxie senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT chengxinluo senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT xiangtaohuang senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT fengtian senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT jiepingchen senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression
AT xili senp1promotesmclpathogenesisthroughregulatingjakstat5pathwayandsocs2expression